Screen Shot 2018-07-16 at 5.52.12 PM_edi

Jeff Lumin


Mr. Lumin, serves as CSO of Beacon Pharmaceutical Prior to Assuming his current role Jeff was a portfolio manager at China Asset Management (a division of CITIC Securities), one of the largest mutual funds in China. At launch, Jeff's team was entrusted the managements of  $4 billion in investment capital. Before moving back to New York, As a life-science specialist, Jeff has traveled to Russia, Brazil, Britain, France, Canada, Belgium, Switzerland, seeking new investment opportunities, conducting investment due-diligence, visiting field operations, and meeting with senior management and scientists.

At Beacon Pharmaceutical, Jeff is responsible for the overall direction of the incubator pipeline of companies.  He reviews, validates and sources companies with compelling IP befitting  the Incubator model.  Jeff also works on licensing  of the IP of small bio-pharmaceutical companies and universities. He aims to find investments in early-stage startups with breakthrough technologies; taking these compounds to meet unmet medical needs. Jeff previously worked as CFO of Ansun Biopharma and was a Partner at Ever Pine Capital Management.

Post his graduation from Yale, Jeff worked with several top fund managers for over a decade. He was a key member of the global equity team with AIG and also with Franklin Templeton.  Jeff a healthcare analyst in both teams, researched and  advised on investments in pharmaceutical, biotech, medical device companies, globally.  Jeff received his MBA from Yale School of Management and Master of Science. and Master of Physiology from Yale School of Medicine.